FiercePharma has the scoop:
. . . .Merck has agreed to purchase bankrupt Hawaii Biotech's dengue fever vaccine unit for an undisclosed sum. It's a critical move for Hawaii, which filed for Chapter 11 bankruptcy protection last year and will deplete a $2 million credit line by the end of this month. . . .
This will add, albeit marginally, to the neglected diseases initiative at Whitehouse Station.
